Ashendel CL - Search Results

1

D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.

Juang SH, Lung CC, Hsu PC, Hsu KS, Li YC, Hong PC, Shiah HS, Kuo CC, Huang CW, Wang YC, Huang L, Chen TS, Chen SF, Fu KC, Hsu CL, Lin MJ, Chang CJ, Ashendel CL, Chan TC, Chou KM, Chang JY. Juang SH, et al. Among authors: ashendel cl. Mol Cancer Ther. 2007 Jan;6(1):193-202. doi: 10.1158/1535-7163.MCT-06-0482. Mol Cancer Ther. 2007. PMID: 17237279

2

Synthesis and MEK1 inhibitory activities of imido-substituted 2-chloro-1,4-naphthoquinones.

Bakare O, Ashendel CL, Peng H, Zalkow LH, Burgess EM. Bakare O, et al. Among authors: ashendel cl. Bioorg Med Chem. 2003 Jul 17;11(14):3165-70. doi: 10.1016/s0968-0896(03)00267-0. Bioorg Med Chem. 2003. PMID: 12818679

3

Characterization of the in vivo sites of serine phosphorylation on Lck identifying serine 59 as a site of mitotic phosphorylation.

Kesavan KP, Isaacson CC, Ashendel CL, Geahlen RL, Harrison ML. Kesavan KP, et al. Among authors: ashendel cl. J Biol Chem. 2002 Apr 26;277(17):14666-73. doi: 10.1074/jbc.M111911200. Epub 2002 Feb 14. J Biol Chem. 2002. PMID: 11847223 Free article.

4

Bioactive compounds from Psorothamnus junceus.

Zhang H, Li X, Ashendel CL, Chang CJ. Zhang H, et al. Among authors: ashendel cl. J Nat Prod. 2000 Sep;63(9):1244-8. doi: 10.1021/np990171l. J Nat Prod. 2000. PMID: 11000028

5

Novel protein kinase C inhibitors: synthesis and PKC inhibition of beta-substituted polythiophene derivatives.

Xu WC, Zhou Q, Ashendel CL, Chang CT, Chang CJ. Xu WC, et al. Among authors: ashendel cl. Bioorg Med Chem Lett. 1999 Aug 2;9(15):2279-82. doi: 10.1016/s0960-894x(99)00375-3. Bioorg Med Chem Lett. 1999. PMID: 10465561

6

Novel protein kinase C inhibitors: alpha-terthiophene derivatives.

Kim DS, Ashendel CL, Zhou Q, Chang CT, Lee ES, Chang CJ. Kim DS, et al. Among authors: ashendel cl. Bioorg Med Chem Lett. 1998 Oct 6;8(19):2695-8. doi: 10.1016/s0960-894x(98)00468-5. Bioorg Med Chem Lett. 1998. PMID: 9873605

7

Workgroup 3: transgenic and reconstitution models of prostate cancer.

Green JE, Greenberg NM, Ashendel CL, Barrett JC, Boone C, Getzenberg RH, Henkin J, Matusik R, Janus TJ, Scher HI. Green JE, et al. Among authors: ashendel cl. Prostate. 1998 Jun 15;36(1):59-63. doi: 10.1002/(sici)1097-0045(19980615)36:1<59::aid-pros11>3.0.co;2-h. Prostate. 1998. PMID: 9650918 No abstract available.

8

Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.

Ramocki MB, Johnson SE, White MA, Ashendel CL, Konieczny SF, Taparowsky EJ. Ramocki MB, et al. Among authors: ashendel cl. Mol Cell Biol. 1997 Jul;17(7):3547-55. doi: 10.1128/MCB.17.7.3547. Mol Cell Biol. 1997. PMID: 9199290 Free PMC article.

9

Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk.

Furlong MT, Mahrenholz AM, Kim KH, Ashendel CL, Harrison ML, Geahlen RL. Furlong MT, et al. Among authors: ashendel cl. Biochim Biophys Acta. 1997 Feb 4;1355(2):177-90. doi: 10.1016/s0167-4889(96)00131-0. Biochim Biophys Acta. 1997. PMID: 9042338 Free article.

10

Inhibition of intracellular Ca2+ signalling, cytotoxicity and antitumor activity of the herbicide oryzalin and its analogues.

Powis G, Gallegos A, Abraham RT, Ashendel CL, Zalkow LH, Dorr R, Dvorakova K, Salmon S, Harrison S, Worzalla J. Powis G, et al. Among authors: ashendel cl. Cancer Chemother Pharmacol. 1997;41(1):22-8. doi: 10.1007/s002800050703. Cancer Chemother Pharmacol. 1997. PMID: 9443610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters